Population
Populations at risk of norovirus infection and transmission, including young children, the elderly, the…
Design
Review
Authors
Loading...
Norovirus burden in vulnerable groups prioritizes vaccine development; leaves open optimal strain coverage and efficacy trials.
This review discusses the challenges and progress in developing human norovirus vaccines and identifying target populations for implementation.
Aliabadi et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: